- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant humanised monoclonal IgG2 lambda antibody agains
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant humanised monoclonal IgG2 lambda antibody against human sclerostin
| EU orphan designation number: | EU/3/16/1686
|
| Active ingredient: | Recombinant humanised monoclonal IgG2 lambda antibody against human sclerostin |
| Indication: | Treatment of osteogenesis imperfecta |
| Sponsor: | Mereo Biopharma Group Limited
4th Floor, 1 Cavendish Place, London W1G 0QF, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 29/06/2016 | Orphan designation | EMA/OD/052/16 | (2016)4127 of 27/06/2016 |
CONTACT
EU links
Directorate General Health & Consumers